| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74341 |
Vc-MMAE， cas:646502-53-6，ADC定制 |
128 |
wyh |
2024-12-19 |
| 74342 |
Azido-PEG4-MMAE |
112 |
zyl |
2024-12-19 |
| 74343 |
cas:2055024-59-2，Fmoc-PEG2-Val-Cit-PAB-OH |
113 |
zyl |
2024-12-19 |
| 74344 |
Azide-PEG6-Val-Cit-PAB-PEG6- Biotin，ADC定制 |
116 |
wyh |
2024-12-19 |
| 74345 |
Ga-DOTA-(Asp)n 大环DOTA共轭(Asp)n肽 |
70 |
h |
2024-12-19 |
| 74346 |
cas:1807530-16-0，2-hydroxyethyl disulfide mono-Tosylate- ADC linker |
87 |
zyl |
2024-12-19 |
| 74347 |
DOTA偶联受体特异性肽 |
116 |
h |
2024-12-19 |
| 74348 |
聚乙二醇化DOTA-AHA基GdIII螯合物 PEGylated DOTA-based gadolinium(III) |
94 |
h |
2024-12-19 |
| 74349 |
PAMAM树状大分子DOTA缀合物 PAMAM–DOTA |
98 |
h |
2024-12-19 |
| 74350 |
ALD-tetra-EG-Osu的介绍 |
120 |
zyl |
2024-12-19 |
| 74351 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
216 |
h |
2024-12-19 |
| 74352 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
90 |
h |
2024-12-19 |
| 74353 |
cas:55750-63-5，Mal-heptanoic NHS ester |
109 |
zyl |
2024-12-19 |
| 74354 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
97 |
h |
2024-12-19 |
| 74355 |
cas:663599-10-8，DMAC-SPP |
103 |
zyl |
2024-12-19 |
| 74356 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
141 |
h |
2024-12-19 |
| 74357 |
PEG-pGlu(DOTA)8-LA4 |
54 |
h |
2024-12-19 |
| 74358 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
141 |
zyl |
2024-12-19 |
| 74359 |
DOTA-Hyd-TRP PET示踪剂 |
102 |
h |
2024-12-19 |
| 74360 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
143 |
h |
2024-12-19 |
| 74361 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
79 |
zyl |
2024-12-19 |
| 74362 |
DOTA-ALN DOTA-阿仑膦酸盐 |
84 |
h |
2024-12-19 |
| 74363 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
145 |
h |
2024-12-19 |
| 74364 |
cas:906564-59-8，Propargyl-C2-NHS ester |
98 |
zyl |
2024-12-19 |
| 74365 |
DOTA-Gp2-EGFR DOTA螯合剂标记结合表皮生长因子受体EGFR靶向Gp2 |
87 |
h |
2024-12-19 |
| 74366 |
cas:894095-98-8，β-D-glucuronide-pNP-carbonate |
77 |
zyl |
2024-12-19 |
| 74367 |
DOTA结合肽功能化金纳米粒子 |
91 |
h |
2024-12-19 |
| 74368 |
90Y-DOTA-Bn 钇-90-DOTA-铃蟾肽 |
117 |
h |
2024-12-19 |
| 74369 |
cas:85916-13-8，NH-bis(C1-Boc)，亚氨基二乙酸二异丁酯 |
117 |
zyl |
2024-12-19 |
| 74370 |
Anti-CD19 (clone huB4)-Mc-MMAF-ADC分子 |
70 |
zyl |
2024-12-19 |
| 74371 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
67 |
zyl |
2024-12-19 |
| 74372 |
cas:2353409-70-6 MMAF-methyl ester |
131 |
zyl |
2024-12-19 |
| 74373 |
DOTA-ipilimumab 螯合剂DOTA缀合单克隆抗体ipilimumab |
80 |
h |
2024-12-19 |
| 74374 |
双功能单膦酸Ln-DOTA衍生物 |
107 |
h |
2024-12-19 |
| 74375 |
Cu-DOTA-阿伦膦酸盐 Cu-DOTA-alendronate |
102 |
h |
2024-12-19 |
| 74376 |
Mc-3377的介绍 |
83 |
zyl |
2024-12-19 |
| 74377 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF的介绍 |
81 |
zyl |
2024-12-19 |
| 74378 |
(DOTA)n-PAMAM-[尼妥珠单抗-F(ab’)2]的缀合物 |
86 |
h |
2024-12-19 |
| 74379 |
cas:2055041-39-7 Mal-PEG4-Val-Cit-PAB-OH |
118 |
zyl |
2024-12-19 |
| 74380 |
DBCO-PEG3-Val-Cit-PAB-PNP的介绍 |
132 |
zyl |
2024-12-19 |
| 74381 |
(DOTA)5-十氢赖氨酸(DOTA)5-decalysine |
119 |
h |
2024-12-19 |
| 74382 |
DOTA-HPMA缀合物 DOTA共轭N-(2-羟丙基)甲基丙烯酰胺聚合物 |
95 |
h |
2024-12-19 |
| 74383 |
G3-cNGR肽缀合物 |
121 |
h |
2024-12-19 |
| 74384 |
DOTA-USMSN DOTA偶联介孔二氧化硅纳米颗粒 |
81 |
h |
2024-12-19 |
| 74385 |
Gd-DOTA-CC9 环肽CC9偶联Gd-DOTA |
130 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询